Puma Biotechnology
PBYI
9.60
-0.22
-2.19%
Puma Biotechnology
US · PBYI
#3745 by market cap
9.60
-0.22
-2.19%
Live - 5344 symbols - heartbeat 275s ago
· 2026-10-08 09:58
Pre-market
9.68
-1.33%
After-hours
9.81
0.00%
- Market cap
- 495.29M
- P/E (TTM)i
- 18.81
- P/Bi
- 3.57
- EPSi
- 0.61
- Div yieldi
- 0.00%
- 52W posi
- 91%
Reader sentiment
Are you bullish or bearish on PBYI?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
TD Cowen Maintains Puma Biotechnology(PBYI.US) With Hold Rating, Maintains Target Price $5Market Newswire · 2025/11/8
-
Rating change
HC Wainwright & Co. : The Puma Biotechnology (PBYI.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $7.00.Zhitong Finance · 2024/5/20
-
Rating change
H.C. Wainwright Reaffirms Their Buy Rating on Puma Biotechnology (PBYI)TipRanks · 2023/2/1
-
Puma Biotechnology Inc (PBYI) Q3 2025 Earnings Call Highlights: Revenue Growth Amidst Royalty ...Yahoo Finance · 2025/11/7
-
Rating change
H.C. Wainwright Keeps Their Buy Rating on Puma Biotechnology (PBYI)TipRanks · 2023/6/5
-
Rating change
TD Cowen Maintains Puma Biotechnology(PBYI.US) With Hold Rating, Maintains Target Price $4Market Newswire · 2025/8/8
-
Earnings Call Summary | Puma Biotechnology(PBYI.US) Q4 2025 Earnings ConferenceMarket Newswire · 2026/2/27
-
Rating change
TD Cowen Maintains Puma Biotechnology(PBYI.US) With Hold Rating, Raises Target Price to $5Market Newswire · 2025/11/7
-
Puma Biotechnology Inc (PBYI) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic ...Yahoo Finance · 2026/2/27
-
Rating change
H.C. Wainwright Sticks to Its Buy Rating for Puma Biotechnology (PBYI)TipRanks · 2022/12/9
-
Barclays Maintains Puma Biotechnology(PBYI.US) With Sell Rating, Maintains Target Price $2Market Newswire · 2025/11/7
-
Rating change
H.C. Wainwright Maintains Puma Biotechnology(PBYI.US) With Buy Rating, Maintains Target Price $7Market Newswire · 2025/2/28
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 09:58:52 · For reference only, not investment advice and not tailored to your situation.